Patient Care

Medical Oncology

Key figures
- Inpatient Area: 21F and 22F, No.1 Building
                        16F and 17F, No.2 Building
- 103 staffs:
31 Physicians and 68 Nurses
 - 165 Ward beds

Specialty: Chemotherapy, Targeted therapy and Biotherapy for Malignancies




Introduction of the Department of Medical Oncology 

The Department of Medical Oncology (DMO) was established in 1964. It is one of the earliest departments specializing in cancer chemotherapy in China. There are five sections which includes lung cancer, lymphoma, intestinal cancer, breast cancer and stem cell transplant section (altogether 165 ward beds) in DMO. DMO is now a recognized leading unit in the field of domestic cancer chemotherapy in South China.
 
Diagnosis and Treatment

The major diseases diagnosed and treated by DMO include lymphoma, gastrointestinal cancer, lung cancer, breast cancer, nasopharyngeal carcinoma, head and neck cancer, testicular tumor and bladder cancer, etc.

Patients admitted in DMO are from all over the country and Southeast Asia. In 2010, DMO attends about 54 000 out-patients and 11000 in-patients. DMO owns a sterile ward of laminar flow for bone marrow transplantation and a ward for Phase I clinical trials. Besides conventional chemotherapy, DMO also carries out high dose chemotherapy and bone marrow or peripheral blood stem cell transplantation, high-dose methotrexate chemotherapy with therapeutic drug monitoring, immunotherapy, targeted therapy, individual therapy and maintenance therapy, etc. The outcomes of patients with a variety of tumors admitted in DMO have reached the international level.

DMO is also among the primary National GCP Centers for Clinical Trials of Anticancer Drugs in China. In 1983 DMO was confirmed to be one of the first GCP Centers for Clinical Trials of Anticancer Drugs. From then on, DMO assumes a large number of tasks to evaluate new drug each year. Members of DMO has accumulated rich experience in clinical research for anticancer drugs and made a significant contribution to the development of novel anticancer drugs. Currently, the DMO is the unit of chairman of the Committee of Malignant Lymphoma, Chinese Anti-cancer Association. DMO is also the unit of chairman of the Committee of Chemotherapy/Palliative Therapy/Malignant Lymphoma, Guangdong Anti-cancer Association.

With the joint effort of members, DMO has made great achievements in scientific research work. From 2006 to 2010, altogether 32 research projects have been supported by National Natural Science Fund, provincial and municipal science and technology plans, Provincial Bureau of Public Health Fund, etc. Besides, DMO is productive in papers. In 2010, almost 50 original articles written by members of DMO were published, including 37 papers published on SCI Journals.

DMO has brought up many professionals in cancer chemotherapy and clinical pharmacology for our country, especially the southern part of China. Every year DMO recruits about 15 university graduates including the candidates for masters and Ph.D. degrees in Clinical Oncology or Molecular Medicine. In addition, each year DMO attracts about 40 medical doctors from all over the country coming for professional training.
 
Cancer Care
 
The Department of Medical Oncology provides individualized and comprehensive treatment for various tumors. This department can provide the following care for the tumor mentioned below:
 
Lymphoma: (including non-Hodgkin lymphoma and Hodgkin lymphoma) Chemotherapy and immunotherapy; High-Dose chemotherapy with autologous stem cell rescue
Gastrointestinal cancer: (including esophageal cancer, gastric cancer,colon cancer,rectal cancer,hepatocellular carcinoma, cholangiocarcinoma and pancreatic cancer) Adjuvant chemotherapy, palliative chemotherapy and targeted therapy
Lung cancer: Chemotherapy and targeted therapy
breast cancer: Endocrine therapy, chemotherapy and targeted therapy 
Nasopharyngeal carcinoma: Chemotherapy
Head and neck cancer: (including tongue cancer, laryngeal carcinoma and parotid carcinoma, etc.) Chemotherapy
Testicular tumor and bladder cancer: Adjuvant chemotherapy and palliative chemotherapy
Prostate cancer: Hormone therapy and chemotherapy
Sarcoma: (including osteosarcoma, malignant fibrous histiocytoma of bone, Ewing sarcoma family of tumors and soft tissue sarcoma etc.) Chemotherapy 
 
Facilities and apparatus
 
Wards for Phase I clinical trials
Sterile ward beds of laminar flow
Blood cell separator
Refrigerated centrifuge
Harmful gas purification equipment
Liquid nitrogen container
Ultra low temperature refrigerator
Electro-cardiac monitor
Cardiac defibrillator plus electrical pacemaker
Electrocardiograph
Inverted microscope
Electrophoresis apparatus
 
 
Specialists
 
Currently, there are 20 senior specialists in the department, including 6 PhD supervisors and 7 Master supervisors.
 
Ruihua Xu, M.D., Ph. D
Professor and Vice Director of Sun Yat-Sen University Cancer Center
PhD supervisor, Clinical Oncology
 
Wenqi Jiang, M.D.
Professor and Chairman, Department of Medical Oncology
Director of Lymphoma Research Center, Sun Yat-Sen University Cancer Center
PhD supervisor, Clinical Oncology
 
Li Zhang, M.D.
Professor and Vice Chairman, Department of Medical Oncology
Vice Chair of Lung Cancer Research Center, Sun Yat-Sen University
PhD supervisor, Clinical Oncology
 
Huiqiang Huang, M.D., Ph. D
Professor and Vice Chairman, Department of Medical Oncology
PhD supervisor, Clinical Oncology
 
Tongyu Lin, M.D., Ph. D
Professor and Vice Chairman, Department of Medical Oncology
PhD supervisor, Clinical Oncology
 
Zhongzhen Guan, M.D.
Professor and Supervisor of the Chairman of the Department of Medical Oncology
PhD supervisor, Clinical Oncology
 
Donggeng Liu, M.D.
Associate Professor, Department of Medical Oncology
 
Haiying Wu, M.D.
Associate Professor and Master Supervisor, Department of Medical Oncology
 
Yuhong Li, M.D., Ph. D
Associate Professor and Master Supervisor, Department of Medical Oncology
 
Xiaoyu Teng, M.D.
Associate Professor, Department of Medical Oncology
 
Shusen Wang, M.D., Ph. D
Associate Professor and Master Supervisor, Department of Medical Oncology
 
Zhongyu Yuan, M.D., Ph. D
Associate Professor, Department of Medical Oncology
 
Zhiming Li M.D., Ph. D
Associate Professor and Master Supervisor, Department of Medical Oncology
 
Likun Chen, M.D., Ph. D
Associate Professor and Master Supervisor, Department of Medical Oncology
 
Yanxia Shi, M.D., Ph. D
Associate Professor and Master Supervisor, Department of Medical Oncology
 
Xubin Lin, M.D., Ph. D
Associate Professor, Department of Medical Oncology
 
Ningning Zhou, M.D., Ph. D
Associate Professor, Department of Medical Oncology
 
Qingqing Cai, M.D., Ph. D
Associate Professor and Master Supervisor, Department of Medical Oncology
 
Fenghua Wang, M.D., Ph. D
Associate Professor, Department of Medical Oncology
 
Dongsheng Zhang, M.D., Ph. D
Associate Professor, Department of Medical Oncology
 
Last update in May 2011, content approved by Dr. Li Zhang

Where are we | Contact us|

Copyright:Sun Yat-sen University Cancer Center Designed by Wanhu.